GemPharmatech Co., Ltd. Class A · SSE:688046
GemPharmatech Co., Ltd. Class A shareholders
GemPharmatech Co., Ltd. Class A on 6ix: holders from US fund reports. Largest: Acadian Emerging Markets Portfolio, State Street(R) SPDR(R) Portfolio Emerging Markets ETF and Strategic Advisers Emerging Markets Fund. Each with its filing.
| Holder | Shares | % of GemPharmatech Co., Ltd. Class A | Change | As of |
|---|---|---|---|---|
| Acadian Emerging Markets Portfolio | 433K | new | Jul 31, 2026 | |
| State Street(R) SPDR(R) Portfolio Emerging Markets ETF | 219K | no change | Jun 30, 2026 | |
| Strategic Advisers Emerging Markets Fund | 185K | +114K | May 31, 2026 | |
| Emerging Markets Core Equity 2 Portfolio | 155K | no change | Jul 31, 2026 | |
| State Street(R) SPDR(R) S&P(R) Emerging Markets Small Cap ETF | 51,444 | no change | Jun 30, 2026 | |
| The Emerging Markets Small Cap Series | 37,823 | no change | Jul 31, 2026 | |
| Dimensional Emerging Core Equity Market ETF | 26,751 | no change | Jul 31, 2026 | |
| Dimensional Emerging Markets Core Equity 2 ETF | 22,008 | no change | Jul 31, 2026 | |
| Dimensional World ex. U.S. Core Equity 2 ETF | 12,740 | no change | Jul 31, 2026 | |
| Emerging Markets Social Core Equity Portfolio | 10,762 | no change | Jul 31, 2026 |